These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27129269)

  • 1. Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.
    Fancy RM; Wang L; Zeng Q; Wang H; Zhou T; Buchsbaum DJ; Song Y
    J Biol Chem; 2016 Jun; 291(24):12862-12870. PubMed ID: 27129269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.
    Fancy RM; Kim H; Zhou T; Zinn KR; Buchsbaum DJ; Song Y
    J Cell Biochem; 2017 Aug; 118(8):2285-2294. PubMed ID: 28092099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.
    Yang H; Song Y
    J Mol Model; 2016 Apr; 22(4):89. PubMed ID: 26995783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.
    Fancy RM; Kim H; Napier T; Buchsbaum DJ; Zinn KR; Song Y
    J Cell Biochem; 2018 Jul; 119(7):6216-6230. PubMed ID: 29663486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin binding to the Fas death domain. Regulation by Fas activation.
    Ahn EY; Lim ST; Cook WJ; McDonald JM
    J Biol Chem; 2004 Feb; 279(7):5661-6. PubMed ID: 14594800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
    Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
    Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of calmodulin-Fas death domain interaction: an integrated experimental and computational study.
    Fancy RM; Wang L; Napier T; Lin J; Jing G; Lucius AL; McDonald JM; Zhou T; Song Y
    Biochemistry; 2014 Apr; 53(16):2680-8. PubMed ID: 24702583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the Calmodulin-Binding Domains of Fas Death Receptor.
    Chang BJ; Samal AB; Vlach J; Fernandez TF; Brooke D; Prevelige PE; Saad JS
    PLoS One; 2016; 11(1):e0146493. PubMed ID: 26735300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
    Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
    J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.
    Das S; Tripathi N; Siddharth S; Nayak A; Nayak D; Sethy C; Bharatam PV; Kundu CN
    Apoptosis; 2017 Oct; 22(10):1205-1224. PubMed ID: 28702823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation and free energy analyses of the complex of calcium-bound calmodulin and the Fas death domain.
    Suever JD; Chen Y; McDonald JM; Song Y
    Biophys J; 2008 Dec; 95(12):5913-21. PubMed ID: 18820240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling.
    McDonald ER; Chui PC; Martelli PF; Dicker DT; El-Deiry WS
    J Biol Chem; 2001 May; 276(18):14939-45. PubMed ID: 11279061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intrinsically kinase-inactive EPHB6 receptor predisposes cancer cells to DR5-induced apoptosis by promoting mitochondrial fragmentation.
    El Zawily AM; Toosi BM; Freywald T; Indukuri VV; Vizeacoumar FJ; Leary SC; Freywald A
    Oncotarget; 2016 Nov; 7(47):77865-77877. PubMed ID: 27788485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal and C-terminal domains of calmodulin mediate FADD and TRADD interaction.
    Papoff G; Trivieri N; Marsilio S; Crielesi R; Lalli C; Castellani L; Balog EM; Ruberti G
    PLoS One; 2015; 10(2):e0116251. PubMed ID: 25643035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
    Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5.
    Adams C; Totpal K; Lawrence D; Marsters S; Pitti R; Yee S; Ross S; Deforge L; Koeppen H; Sagolla M; Compaan D; Lowman H; Hymowitz S; Ashkenazi A
    Cell Death Differ; 2008 Apr; 15(4):751-61. PubMed ID: 18219321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.
    Fernandez TF; Samal AB; Bedwell GJ; Chen Y; Saad JS
    J Biol Chem; 2013 Jul; 288(30):21898-908. PubMed ID: 23760276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the complex of calmodulin with the target sequence of calmodulin-dependent protein kinase I: studies of the kinase activation mechanism.
    Clapperton JA; Martin SR; Smerdon SJ; Gamblin SJ; Bayley PM
    Biochemistry; 2002 Dec; 41(50):14669-79. PubMed ID: 12475216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
    Chen Y; Pawar P; Pan G; Ma L; Liu H; McDonald JM
    J Cell Biochem; 2008 Feb; 103(3):788-99. PubMed ID: 17654480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.
    Tur V; van der Sloot AM; Reis CR; Szegezdi E; Cool RH; Samali A; Serrano L; Quax WJ
    J Biol Chem; 2008 Jul; 283(29):20560-8. PubMed ID: 18474604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.